Literature DB >> 18463899

[Alternative and complementary therapies in fibromyalgia syndrome].

J Langhorst1, W Häuser, D Irnich, N Speeck, E Felde, A Winkelmann, H Lucius, A Michalsen, F Musial.   

Abstract

INTRODUCTION: Interdisciplinary S3 level guidelines were devised in cooperation with 8 medical, 2 psychological and 2 patient support groups. Results were elaborated in a multilevel group process.
METHODS: On the bases of the "Cochrane Library" (1993-2006), "Medline" (1980-2006), "PsychInfo" (2006) and "Scopus" (2006) controlled studies and meta-analyses of controlled studies were analyzed.
RESULTS: Only few controlled studies were found supporting in part the effectiveness of CAM therapies in the treatment of fibromyalgia syndrome. Due to the lack of information on long term efficacy and cost-effectiveness, only limited recommendations for CAM therapies can be given.
CONCLUSION: Within a multicomponent therapy setting, selective CAM therapies (acupuncture, vegetarian diet, homeopathy, Tai Chi, Qi Gong, music-oriented and body-oriented therapies) can be recommended for a limited period of time.

Entities:  

Mesh:

Year:  2008        PMID: 18463899     DOI: 10.1007/s00482-008-0677-1

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  42 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  A pilot study of external qigong therapy for patients with fibromyalgia.

Authors:  Kevin W Chen; Afton L Hassett; Faxiang Hou; Joy Staller; Alan S Lichtbroun
Journal:  J Altern Complement Med       Date:  2006-11       Impact factor: 2.579

3.  Psychosocial factors associated with complementary treatment use in fibromyalgia.

Authors:  P M Nicassio; C Schuman; J Kim; A Cordova; M H Weisman
Journal:  J Rheumatol       Date:  1997-10       Impact factor: 4.666

4.  Alternative medicine use in fibromyalgia syndrome.

Authors:  M Pioro-Boisset; J M Esdaile; M A Fitzcharles
Journal:  Arthritis Care Res       Date:  1996-02

5.  Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

Authors:  S Jacobsen; B Danneskiold-Samsøe; R B Andersen
Journal:  Scand J Rheumatol       Date:  1991       Impact factor: 3.641

6.  Electroacupuncture in fibromyalgia: results of a controlled trial.

Authors:  C Deluze; L Bosia; A Zirbs; A Chantraine; T L Vischer
Journal:  BMJ       Date:  1992-11-21

7.  Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: results of a pilot study.

Authors:  P Creamer; B B Singh; M C Hochberg; B M Berman
Journal:  Arthritis Care Res       Date:  2000-08

8.  A pilot study of body awareness programs in the treatment of fibromyalgia syndrome.

Authors:  S A Kendall; K Brolin-Magnusson; B Sören; B Gerdle; K G Henriksson
Journal:  Arthritis Care Res       Date:  2000-10

Review 9.  Functional chronic pain syndromes and naturopathic treatments: neurobiological foundations.

Authors:  Frauke Musial; Andreas Michalsen; Gustav Dobos
Journal:  Forsch Komplementmed       Date:  2008-04-07

10.  Unconventional medicine in the United States. Prevalence, costs, and patterns of use.

Authors:  D M Eisenberg; R C Kessler; C Foster; F E Norlock; D R Calkins; T L Delbanco
Journal:  N Engl J Med       Date:  1993-01-28       Impact factor: 91.245

View more
  10 in total

1.  [Is the dilemma of fibromyalgia solved by the guideline?].

Authors:  M Mindach
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

Review 2.  Chiropractic treatment for fibromyalgia: a systematic review.

Authors:  Edzard Ernst
Journal:  Clin Rheumatol       Date:  2009-06-21       Impact factor: 2.980

3.  Traditional Chinese Medicine for Fibromyalgia.

Authors:  Scott Mist; Cheryl Wright; Kim D Jones; James W Carson; Jean Shih
Journal:  Pract Pain Manag       Date:  2010-09-01

Review 4.  [Complementary and alternative therapies for fibromyalgia syndrome. Systematic review, meta-analysis and guideline].

Authors:  J Langhorst; W Häuser; K Bernardy; H Lucius; M Settan; A Winkelmann; F Musial
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

5.  [German fibromyalgia consumer reports. Benefits and harms of fibromyalgia syndrome therapies].

Authors:  W Häuser; E Jung; B Erbslöh-Möller; M Gesmann; H Kühn-Becker; F Petermann; J Langhorst; T Weiss; R Thoma; A Winkelmann
Journal:  Schmerz       Date:  2012-04       Impact factor: 1.107

6.  Traditional Chinese medicine diagnoses in a sample of women with fibromyalgia.

Authors:  Scott D Mist; Cheryl L Wright; Kim Dupree Jones; James W Carson
Journal:  Acupunct Med       Date:  2011-10-25       Impact factor: 2.267

Review 7.  [Fibromyalgia--the new guideline].

Authors:  W Brückle
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

8.  Systematic review and network meta-analysis of interventions for fibromyalgia: a protocol.

Authors:  Jason W Busse; Shanil Ebrahim; Gaelan Connell; Eric A Coomes; Paul Bruno; Keshena Malik; David Torrance; Trung Ngo; Karin Kirmayr; Daniel Avrahami; John J Riva; Peter Struijs; David Brunarski; Stephen J Burnie; Frances LeBlanc; Ivan A Steenstra; Quenby Mahood; Kristian Thorlund; Victor M Montori; Vishalini Sivarajah; Paul Alexander; Milosz Jankowski; Wiktoria Lesniak; Markus Faulhaber; Małgorzata M Bała; Stefan Schandelmaier; Gordon H Guyatt
Journal:  Syst Rev       Date:  2013-03-13

9.  Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.

Authors:  Winfried Häuser; Bernhard Arnold; Wolfgang Eich; Eva Felde; Christl Flügge; Peter Henningsen; Markus Herrmann; Volker Köllner; Edeltraud Kühn; Detlev Nutzinger; Martin Offenbächer; Marcus Schiltenwolf; Claudia Sommer; Kati Thieme; Ina Kopp
Journal:  Ger Med Sci       Date:  2008-12-09

Review 10.  A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome.

Authors:  Romy Lauche; Holger Cramer; Winfried Häuser; Gustav Dobos; Jost Langhorst
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-13       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.